Medicines For Ireland Lays Out Priorities For Boosting Access To Generics And Biosimilars
A new Irish generics medicines body has published a policy manifesto calling on the government to take action on pricing, competition, biosimilars and market access.
You may also be interested in...
Talks Must Start Now On New Irish Drug Supply Pact
An industry group representing Ireland’s generic-and-biosimilar makers says talks “need to start now” on a new national medicine supply accord to create more affordable access to life-saving drugs, with the association’s members at the negotiating table.
New Irish Generics Body Wants “Fundamental” Reform Of Medicines Procurement
Two generic industry associations have merged to form a single body that includes the largest generic companies in Ireland. Medicines For Ireland has marked its creation by saying it plans to push for a reform of Irish medicines procurement policies, particularly in areas such as tackling drug shortages, and has called for action to promote the use of biosimilars.
FDA’s Califf Calls For Return To Large, Simple Trials Without The ‘Useless Stuff’ That Slows Development
US FDA Commissioner Califf praises both Project Pragmatica and the ‘very powerful’ partnership between OCE Director Rick Pazdur and National Cancer Institute Director Monica Bertagnolli.